Quality Metrics Partners, LLC, Clearview Diagnostics, LLC, CGK Consulting, LLC, CGK Medical Management, LLC, CGK Medical Ventures, LLC, Brodie Flanders, Michael Morales, Michael Knall, Anthony Kim, and Christopher R. Peyton v. Greg Blasingame Capricia Larson Gabby Consulting, LLC And DX Power Moves Consulting, LLC ( 2019 )


Menu:
  • REVERSE and REMAND; and Opinion Filed August 26, 2019.
    In The
    Court of Appeals
    Fifth District of Texas at Dallas
    No. 05-18-00394-CV
    QUALITY METRICS PARTNERS, LLC, CLEARVIEW DIAGNOSTICS, LLC, CGK
    CONSULTING, LLC, CGK MEDICAL MANAGEMENT, LLC, CGK MEDICAL
    VENTURES, LLC, BRODIE FLANDERS, MICHAEL MORALES, MICHAEL KNALL,
    ANTHONY KIM, AND CHRISTOPHER R. PEYTON, Appellants
    V.
    GREG BLASINGAME; CAPRICIA LARSON; GABBY CONSULTING, LLC; AND DX
    POWER MOVES CONSULTING, LLC, Appellees
    On Appeal from the 101st Judicial District Court
    Dallas County, Texas
    Trial Court Cause No. DC-17-03702
    MEMORANDUM OPINION
    Before Justices Brown, Schenck, and Pedersen, III
    Opinion by Justice Pedersen, III
    Appellants challenge the trial court’s denial of their consolidated motions to compel
    arbitration of certain claims brought by appellees. In two issues, appellants contend that (i) the
    claims at issue fall within the scope of the agreement containing an arbitration provision, and (ii)
    three legal theories allow these appellants to compel arbitration of those claims. We reverse the
    trial court’s order denying the motion to compel, render judgment ordering all disputes between
    the parties to proceed to arbitration, and remand for further proceedings consistent with this
    opinion.
    Background
    This appeal involves a series of contractual relationships among the parties.
    The Parties
    Appellant Quality Metrics Partners, LLC (QMP) provides marketing services, including
    sales and client acquisition to vendors of services and products of interest to health care providers.
    It owns and operates a laboratory, appellant Clearview Diagnostics, LLC (Clearview), which
    processes blood and urine samples. Individual appellants Brodie Flanders, Michael Morales,
    Michael Knall, and Anthony Kim are principals of both QMP and Clearview. In this opinion, we
    will refer to QMP, Clearview, Flanders, Morales, Knall, and Kim as the QMP Appellants.
    Individual appellant Christopher Peyton is the Chief Executive Officer of CKG Consulting,
    LLC1 and CGK Medical Ventures, LLC. In this opinion, we will refer to CGK, CGK Medical
    Ventures, LLC, and Peyton as the CGK Appellants.
    Appellees Greg Blasingame and Capricia Larson are principals of DX Power Moves
    Consulting, LLC (DX Power) and its predecessor in interest, Gabby Consulting, LLC (Gabby).
    We refer to these four parties collectively as appellees.
    The Agreements
    On November 18, 2015, QMP and CGK entered into their Representative Marketing
    Agreement. In that agreement, CGK agreed to provide information to physicians and other health
    care professionals and health care organizations regarding specific services and products of
    Clearview. QMP subsequently assigned its interest in the Representative Marketing Agreement to
    Clearview itself. The new agreement was titled the Marketing Services Agreement, and it
    continued all obligations relevant to this appeal.
    1
    During the course of the parties’ relationship, CGK Consulting, LLC changed its name to CGK Medical Management, LLC. “CGK” shall
    refer here to both entities.
    –2–
    Appellees contend that, during that same month, they entered into an oral contract with the
    QMP Appellants. Appellees agreed to market QMP and Clearview’s services to appellees’ health-
    care-provider clients. In return, appellees would receive 40% of QMP’s and Clearview’s gross
    collections after processing samples provided by appellees’ clients.
    And the same month, appellees contend, the QMP Appellants persuaded Gabby to enter a
    written agreement with CGK. That agreement, titled the Distribution Agreement, likewise
    provided that appellees would market Clearview’s services to appellees’ health-care clients. Under
    the written agreement, appellees would receive 40% of CGK’s gross collections from Clearview’s
    processing of appellees’ clients’ samples. The Distribution Agreement contains an arbitration
    provision, which states that disputes under or relating to the agreement will be submitted to
    arbitration.
    Proceedings Below
    After a year of business dealings among the parties, appellees sued all appellants. They
    alleged breach of the Distribution Agreement by CGK. And they pleaded claims against all
    appellants for conversion and civil threat, violations of the Texas Theft Liability Act, unjust
    enrichment/restitution, civil conspiracy, constructive trust, fraud, negligent misrepresentation,
    tortious interference with contract, and breach of fiduciary duty. Finally, they pleaded a claim of
    aiding and abetting against individual appellants Morales, Knall, Flanders, and Kim.
    Appellants answered and then filed motions to compel arbitration pursuant to the
    Distribution Agreement’s arbitration provision.
    Days later, appellees filed their First Amended Petition, which added allegations of the
    existence and breach of a separate oral agreement with the QMP Appellants. The amended petition
    also claimed that the QMP Appellants had fraudulently induced appellees to enter into that oral
    agreement.
    –3–
    The motions to compel were heard together by the Associate Judge; she ordered arbitration
    of all claims against all appellants. Appellees appealed, and the trial court heard the motions de
    novo. The court granted the motions except as to direct claims against the QMP Appellants.
    This appeal followed.
    Non-Signatories Compelling Arbitration
    We begin with appellants’ second issue, which argues that the QMP Appellants—who are
    not signatories to the Distribution Agreement—can nevertheless compel arbitration with appellees
    via any of three legal theories: third-party-beneficiary status, intertwined estoppel, and same-
    transaction agreements. Whether a claim involving a non-signatory must be arbitrated is a
    “gateway matter” for the trial court that is subject to de novo review on appeal. Jody James Farms,
    JV v. Altman Grp., Inc., 
    547 S.W.3d 624
    , 629 (Tex. 2018).
    “Arbitration is a creature of contract between consenting parties.” 
    Id. Nevertheless, principles
    of contract law and agency may require a party that agreed to arbitrate disputes with one
    party to arbitrate with another. 
    Id. The parties
    before us agree that the Federal Arbitration Act
    (FAA) and federal law generally govern their case. But the United States Supreme Court has
    directed that we look to state law to determine whether contracts are binding and enforceable under
    the FAA when that state law would govern issues of “validity, revocability, and enforceability of
    contracts generally.” Arthur Andersen LLP v. Carlisle, 
    556 U.S. 624
    , 630–31 (2009). The Carlisle
    Court identified a list of state law principles that allow a contract to be enforced by or against
    nonparties to the contract: assumption, piercing the corporate veil, alter ego, incorporation by
    reference, third-party beneficiary theories, waiver, and estoppel. 
    Id. at 631
    (citing 21 Richard A.
    Lord, Williston on Contracts § 57:19, p. 183 (4th ed. 2001)). Thus, “[i]f a written arbitration
    provision is made enforceable against (or for the benefit of) a third party under state contract law,
    the [FAA’s] terms are fulfilled.” 
    Id. –4– The
    QMP Appellants’ first argument is that they are intended third-party beneficiaries of
    the Distribution Agreement. “A third party may enforce a contract it did not sign when the parties
    to the contract entered the agreement with the clear and express intention of directly benefitting
    the third party.” Tawes v. Barnes, 
    340 S.W.3d 419
    , 425 (Tex. 2011). We determine whether the
    contracting parties intended to benefit a third party directly by looking to the contract’s language,
    construed as a whole. First Bank v. Brumitt, 
    519 S.W.3d 95
    , 102 (Tex. 2017). We are assisted in
    this effort by a relatively unusual example of contract drafting. The Distribution Agreement
    contains a clause specifically acknowledging that it intends such beneficiaries:
    THIRD-PARTY BENEFICIARY
    The Distributor is aware that CGK acts as an independent contractor for
    multiple Service Providers. The services that the Distributor will be providing for
    CGK are also intended to benefit such Service Providers. As a result, the Distributor
    acknowledges that the Service Providers shall be considered to be a third party
    beneficiary of this Agreement. Consequently, the protections and benefits to CGK
    under this Agreement shall also be afforded to the Service Providers.
    This clause identifies a category of parties—service providers—that are entitled to the protections
    and benefits of the Distribution Agreement. Certainly one of those protections or benefits is the
    right to compel arbitration in a dispute relating to the agreement. In re NEXT Fin. Group, Inc., 
    271 S.W.3d 263
    , 267 (Tex. 2008) (intended third-party beneficiary may compel arbitration in
    accordance with terms of agreement).
    The term “service providers,” however, is not defined within the Distribution Agreement,
    and the parties disagree as to who is included within its ambit. Appellees argue that no QMP
    Appellant is specifically identified as a service provider, and they contend that—as between the
    QMP Appellants and CGK—if one is a service provider it would be CGK, who provides marketing
    services for those appellants. These arguments are unavailing. First, a third-party beneficiary need
    not be identified by name; identification of a class or category of parties is sufficient. Freeman v.
    Harleton Oil & Gas, Inc., 
    528 S.W.3d 708
    , 746 (Tex. App.—Texarkana 2017, pet. denied). And
    –5–
    second, we cannot interpret the contract in a manner that would make a signatory (CGK) its own
    third-party beneficiary.2
    Appellants contend that Clearview is a service provider under the Distribution Agreement.
    They contend further that QMP (as Clearview’s predecessor in interest) and Morales, Knall,
    Flanders, and Kim (as agents of QMP and Clearview) are also service providers. Our primary
    concern in addressing appellants’ arguments is to ascertain the true intention of the parties as it is
    expressed in the agreement. See Coker v. Coker, 
    650 S.W.2d 391
    , 393 (Tex. 1983). To that end,
    we “examine and consider the entire writing in an effort to harmonize and give effect to all the
    provisions of a contract so that none will be rendered meaningless.” 
    Id. We begin
    with the third-party provision itself. This section affirms that appellees were
    aware at the time the agreement was made “that CGK acts as an independent contractor for
    multiple Service Providers.” The agreements between CGK on the one hand, and QMP and
    Clearview on the other, state specifically that their relationship is one of independent contractor.
    And while it is true that CGK has provided marketing services for QMP and Clearview, it is equally
    true that Clearview provides laboratory services to CGK’s clients. Indeed, those laboratory
    services are the source of the revenue within all of the contractual relationships implicated in this
    appeal. The third-party provision declares that “[t]he services that [appellees] will be providing for
    CGK are also intended to benefit such Service Providers.” Certainly appellees’ marketing services
    are intended to benefit Clearview directly and QMP, its owner, indirectly. It is difficult to posit
    what other parties would be benefitted by appellees’ efforts; appellees point out in another context
    that the Distribution Agreement was not exclusive, but surely appellees’ efforts were not intended
    2
    Appellees also suggest that interpreting the Distribution Agreement to name the QMP Appellants as third-party beneficiaries would violate
    a provision in the Master Service Agreement prohibiting CGK’s binding QMP or Clearview in any fashion. Of course appellees have no standing
    to complain of CGK’s purported breach of that agreement. And if CGK actually violated the Master Service Agreement by creating the third-party
    beneficiary provision with the intention of its applying to QMP and Clearview, the latter have clearly waived any objection by moving to compel
    arbitration under that provision.
    –6–
    to benefit other marketers under CGK’s direction, i.e., appellees’ competitors. It appears, therefore,
    that the third-party provision would reasonably apply to QMP and Clearview if we look solely to
    that provision.
    We are instructed, though, to look at the entire contract to determine the signing parties’
    intent. See 
    Coker, 650 S.W.2d at 393
    . When we do so, it becomes apparent that the term “service
    provider” permeates the Distribution Agreement:
         appellees agreed not to influence clients and prospective clients of the service providers
    that CGK represents to seek products or services that compete with those marketed by
    CGK;3
         appellees agreed to provide workers’ compensation insurance for their employees and to
    indemnify CGK and its service providers for claims arising out of employee injuries;4
         appellees agreed to indemnify CGK and its service providers from claims incurred because
    of appellees’ breach of the Distribution Agreement;5
    3
    Non-Exclusive Relationship. Distributor may represent, perform services for, and contract with as many additional clients,
    persons, or companies as Distributor, in Distributor’s sole discretion, sees fit. Notwithstanding the preceding sentence,
    Distributor agrees to not, either directly or indirectly, influence CGK’s clients or prospective clients, and the clients and
    prospective clients of the service providers CGK represents, to seek products or services that directly compete with the
    products or services provided and marketed by CGK, or either directly or indirectly influence CGK’s clients or prospective
    clients to seek the same products or services offered by CGK, through another company, entity, or person.
    Distributor Agreement § 4.1 (emphasis added).
    4
    Insurance. Distributor agrees to provide workers' compensation Insurance for Distributor’s employees and agents and
    agrees to hold harmless and indemnify CGK and its service providers for any and all claims arising out of any injury,
    disability, or death of any of Distributor’s employees or agents. Distributor further agrees to maintain adequate amounts of
    general comprehensive liability insurance.
    
    Id. § 4.3
    (emphasis added).
    5
    Indemnity. Distributor agrees to indemnify, defend, and hold CGK, and its service providers free and harmless from all
    claims, demands, losses, costs, expenses, obligations, liabilities, damages, recoveries, and deficiencies, including interest
    penalties, attorneys’ fees, and costs, that CGK and its service providers may incur as a result of a breach by Distributor of
    any representation or agreement contained in this Agreement.
    
    Id. § 4.5
    (emphasis added).
    –7–
         appellees agreed to hold in confidence—and not to disclose without prior consent of CGK
    and its service providers—any proprietary information critical to CGK’s or its service
    providers’ business;6
         appellees recognized and agreed not to impair the interest or value of CGK and its service
    providers in their trademarks, service marks, and trade names;7
         appellees agreed that the contract could be terminated on thirty days’ notice if appellees
    made a willful misrepresentation that was material to the operation of CGK or its service
    providers;8 and
    6
    Confidentiality. Distributor shall hold in the strictest confidence, and shall at no time, without the prior written consent of
    CGK, and its service providers, during this Agreement use for Distributor or others, or disclose to others, directly or
    indirectly, any confidential information, trade secrets or other proprietary matters critical in any way relating to CGK’s and
    its service providers business, including without limitation, the names, representatives, or contact information of any of
    CGK’s service providers (and names of their services), names of subject matter experts, proprietary technology, know·how,
    patent applications, business plans, budget, forecast, client and prospective client’s confidential information and any
    information which has come to Distributor’s attention during the course of Distributor’s association with CGK, either prior
    to or after the Effective Date.
    
    Id. § 5.0
    (emphasis added).
    7
    Use of Trademarks. Distributor recognizes CGK and its service providers right, title, and interest in and to all service
    marks, trademarks, and trade names used by CGK and its service provider[s], and agrees not to engage in any activities or
    commit any acts, directly or indirectly, that may contest, dispute, or otherwise impair CGK and its service provider[s’] right,
    title, and interest therein, nor shall Distributor cause diminishment of the value of said trademarks or trade names through
    any act or representation. Distributor shall not apply for, acquire, or claim any right, title, or interest in or to any such service
    marks, trademarks, or trade names or others that may be confusingly similar to any of them, through advertising or otherwise.
    Effective as of the termination of this Agreement. Distributor shall cease to use all of CGK and its service provider[s’]
    trademarks, marks, and trade names.
    
    Id. § 5.2
    (emphasis added).
    8
    Thirty (30) day Termination. This Agreement may be terminated on thirty (30) days prior written notice for the following
    reasons:
    (a) A breach of any provision of this Agreement by the other party;
    (b) Willful misrepresentation by the Distributor that is material to the operation of CGK, or its service provider[s];
    (e) Failure or refusal on the Distributor’s part to comply with reasonable directives of CGK, or the written policies or
    procedures of CGK.
    
    Id. § 6.2
    (emphasis added).
    –8–
         appellees agreed that the contract could be terminated immediately by CGK for “malicious
    misconduct” detrimental to CGK or its service providers or embezzlement of monies
    belonging to CGK or its service providers.9
    Within the Distribution Agreement, thus, “service providers” are clearly entities or individuals
    whose work is bound up with CGK’s work. At each place in the agreement that CGK requires
    protection from Gabby, it requires that its service providers be protected as well.
    It is undisputed that CGK’s work was bound up with QMP and Clearview. The Master
    Services Agreement, which embodied and controlled their relationship, obligated CGK to provide
    the medical community information regarding the toxicology and blood lab services of Clearview.
    We conclude that Clearview and its predecessor in interest and owner, QMP, have precisely the
    relationship with CGK that is suggested by the multiple references to service providers throughout
    the Distribution Agreement.
    Finally, this construction of the Distribution Agreement aligns with appellees’ factual
    allegations concerning the origins of the Distributor Agreement. According to appellees, the oral
    agreement between them and the QMP Appellants was insufficient to effectuate their relationship
    entirely. Instead, the QMP Appellants asked appellees to enter into the Distribution Agreement
    with CGK, saying it was customary for all their marketing groups, like appellees, to execute a
    written distributor agreement with CGK. Appellees’ allegation suggests that CGK acted in some
    fashion as an overseer of entities providing marketing services for Clearview. It would be
    9
    Immediate Termination. This Agreement may be terminated immediately by CGK, for the following reasons:
    (a) A breach of Section 4.1 of this Agreement by the Distributor;
    (b) Malicious misconduct that is detrimental to CGK, and its service provider[s] (including Affiliated; or
    (c) Embezzlement of monies belonging to CGK or its service provider[s].
    (d) Failure to maintain working relationship with Medical Professionals.
    
    Id. § 6.3
    (emphasis added).
    –9–
    reasonable for QMP and Clearview to require their interests to be protected in those marketers’
    agreements. We conclude the parties to the Distributor Agreement intended QMP and Clearview,
    as service providers to the CGK Appellants, to be third-party beneficiaries of that agreement.
    Because QMP and Clearview are third-party beneficiaries of the Distribution Agreement,
    their agents are as well. See Ascendant Anesthesia PLLC v. Abazi, 
    348 S.W.3d 454
    , 462 (Tex.
    App.—Dallas 2011, no pet.) (“When the principal is bound under the terms of a valid arbitration
    clause, its agents, employees, and representatives are covered by that agreement.”). Thus, the
    individuals who are principals of both QMP and Clearview—Morales, Knall, Flanders, and Kim—
    are also entitled to the protection and benefit of the arbitration agreement.
    We conclude the QMP Appellants are entitled to compel arbitration under the arbitration
    clause contained within the Distribution Agreement. We sustain appellants’ second issue.
    Scope of the Arbitration Clause
    Our next inquiry, based on appellants’ first issue, asks whether the claims appellees urge
    against the QMP Appellants fall within the scope of the Distribution Agreement’s arbitration
    clause. We review de novo the trial court’s ruling that the arbitration provision in the Distribution
    Agreement does not apply to any claims asserted directly against the QMP Appellants. See Henry
    v. Cash Biz, LP, 
    551 S.W.3d 111
    , 115 (Tex. 2018) (whether claims in dispute fall within scope of
    valid arbitration agreement is question of law, which is reviewed de novo).
    Appellants argue that all of appellees’ claims fall within the scope of the arbitration
    agreement. It is undisputed that claims against the CGK Appellants must be arbitrated: those
    parties are signatories or agents of signatories. See 
    Abazi, 348 S.W.3d at 462
    (“[E]xtending the
    scope of an arbitration provision to an agent of the party who signed the agreement furthers the
    federal policy of favoring arbitration and the parties’ intent to provide a single forum to resolve
    disputes arising under an agreement.”). And appellees concede that their “claims against the QMP
    –10–
    Appellants that are derivative of CGK Appellants’ liability or where QMP Appellants would be
    vicariously liable for conduct of CGK Appellants, such as conspiracy or aiding and abetting, [] are
    within the scope of the arbitration provision in the Distributor Agreement.” But appellees contend
    that their direct claims against the QMP Appellants do not rely on the terms or the existence of the
    Distribution Agreement, and thus those claims are not within the scope of the arbitration provision.
    We disagree.
    Under the FAA, ordinary principles of state contract law determine whether parties agreed
    to arbitrate a certain matter. First Options of Chicago, Inc. v. Kaplan, 
    514 U.S. 938
    , 944 (1995).
    The scope of an arbitration agreement must be broadly interpreted in light of the federal policy
    favoring arbitration. In re NEXT Fin. 
    Group, 271 S.W.3d at 267
    . The arbitration clause in the
    Distribution Agreement states:
    ARBITRATION OF DISPUTES
    In the event of any dispute under or relating to the terms of this Agreement,
    or breach thereof, it is agreed that the same will be submitted to arbitration in
    Dallas, Texas. Any judgment upon the award rendered by the arbitrator(s) may be
    entered in any court, state or federal, having jurisdiction thereof.
    Courts employ a strong presumption in favor of arbitration when deciding whether claims fall
    within an arbitration agreement. In re Rubiola, 
    334 S.W.3d 220
    , 225 (Tex. 2011) (orig.
    proceeding). This presumption particularly applies when the clause is characterized legally as
    “broad.” In re Signor, No. 05-16-00703-CV, 
    2017 WL 1046770
    , at *4 (Tex. App.—Dallas
    Mar. 20, 2017, no pet) (mem. op.). We have concluded that “similar arbitration provisions that
    employ terms like ‘any dispute’ and ‘relating to’ are broad arbitration clauses capable of expansive
    reach and create a presumption of arbitrability.” 
    Id. at *6.
    The arbitration clause in this case
    employs both of those terms. We conclude as a threshold matter that the arbitration clause is broad
    within the meaning of federal and Texas law.
    –11–
    A broad arbitration clause, however, is not limitless. We determine whether claims fall
    within the scope of the clause by focusing on the factual allegations of the petition, not the legal
    causes of action asserted there. In re 
    Rubiola, 334 S.W.3d at 225
    . “Generally, if the factual
    allegations ‘touch matters,’ are ‘factually intertwined,’ have a ‘significant relationship’ to, or are
    ‘inextricably enmeshed’ with the contract containing the arbitration provision, the claim is
    arbitrable.” In re Signor, 
    2017 WL 1046770
    , at *4. Moreover, even if some claims are not
    otherwise arbitrable, they can become arbitrable when factually intertwined with arbitrable claims.
    
    Abazi, 348 S.W.3d at 462
    .
    Appellees’ factual allegations are set forth in their First Amended Petition. Among those
    allegations are:
    In November 2015, members of Clearview and QMP solicited appellees to enter
    into an oral agreement, which involved appellees bringing their book of business
    (i.e. their client doctors and their blood and urine samples) to Clearview and QMP.
    In exchange, appellees would receive 40% gross of all collections. Clearview and
    QMP would cover all expenses, handle the accounting, process the samples, and
    split the other 60%.
    Clearview and QMP represented and marketed their “state of the art” and unrivaled
    collection and billing process, which they guaranteed: would bring appellees
    significant profits; showed a bill collection rate drastically higher than industry
    norms and billing practices that allowed them to bill and process samples faster and
    more efficiently than any competitor; and would allow appellees and their clients
    to log-in to an online portal and track the processing of samples in real time and
    also trace the gross and net revenues from their partners.
    Clearview and QMP also represented that the Clearview lab was properly registered
    with all the major insurance companies and licensed to take both in-network and
    out-of-network samples.
    At a dinner attended by Kim, Flanders, Knall, and Morales, the QMP Appellants
    repeated these representations and assured and promised appellees that their
    business venture would be extremely profitable, generating substantial returns
    because of their organization in accounting, insurance, and projected revenue.
    Based on these representations made by the members of QMP and Clearview,
    appellees began taking all of their clients to the Clearview laboratories to promote
    Clearview’s and QMP’s business and registering their clients with Clearview’s
    laboratories.
    –12–
    Also in November of 2015, Morales, Flanders, and Knall introduced Peyton, the
    CEO of CGK, to appellees. QMP and Clearview asked appellees to execute a
    written distributor agreement with CGK, separate from the partnership agreement
    with QMP and Clearview. They stated it was customary to have all marketing
    groups, like appellees, also execute a written distributor agreement with Peyton and
    his company, CGK. Under this agreement, appellees were to perform marketing
    services for CGK and bring in business by securing clients and specimens and
    referring clients to CGK. Appellees were to receive 40% of the gross collections
    after all samples were billed to the health insurance payors.
    Over the next calendar year, per the terms of the two agreements, appellees sent
    millions of dollars’ worth of samples to appellants, but appellants’ prior
    representations and promises turned out to be false and grossly misleading.
    In addition, over the following year, appellants’ misrepresentations and omissions
    included:
    1. Appellants allegedly failed to collect any money in January and February
    of 2016 because “they failed to register with the Insurance payors” despite
    the prior representations they had properly done so;
    2. Despite appellees’ repeated requests, appellants refused to provide them
    with basic information and failed to properly account for their profits;
    3. Appellants violated the terms of their agreements by doing side deals and
    unilaterally changing the terms and payment structure of the agreement
    multiple times without appellees’ consent;
    4. Clearview was not a licensed in-network provider as they represented;
    and
    5. On information and belief, appellants were hiding money, holding
    collections, and using separate billing agents so they did not have to report
    the samples to appellees with the others, or simply sending them out to other
    agents to run and bill and not reporting them to appellees.
    Appellees argue that the facts underlying the two agreements—their oral agreement with
    the QMP Appellants and their Distribution Agreement with the CGK Appellants—are entirely
    different. We cannot agree. Appellees rely upon the same fundamental representations, including
    projected billable and collection rates, the QMP Appellants’ licenses, and the capabilities of the
    Portal system, to state their fraudulent inducement claim against the QMP Appellants and their
    negligent misrepresentation claim against all appellants. Appellees plead two breach of contract
    claims, but both identify the breach as the failure to pay what was owed appellees. And what was
    –13–
    owed appellees under both agreements was the same 40% of gross collections by all appellants.
    Appellees plead a total amount of samples they submitted to appellants; they do not identify any
    damages that purportedly flow from one group of appellants as opposed to the other. We conclude
    that appellees’ allegations regarding misrepresentations and breaches of the agreements are
    factually intertwined with the Distribution Agreement and are factually intertwined with identical
    claims against the CGK Appellants. Accordingly, we conclude those claims are arbitrable. See In
    re Signor, 
    2017 WL 1046770
    , at *4 (claims factually intertwined with the contract); see also 
    Abazi, 348 S.W.3d at 462
    (claims factually intertwined with arbitrable claims).
    We conclude further that the arbitration provision applies to appellees’ tort claims. The
    factual allegations underlying all of the tort claims involve appellants’ failure to remit the identical
    payments allegedly due pursuant to the oral contract and the Distribution Agreement. “Texas
    courts have construed similar broad language in arbitration provisions to encompass tort claims.”
    AdvoCare GP, LLC v. Heath, No. 05-16-00409-CV, 
    2017 WL 56402
    , at *6 (Tex. App.—Dallas
    Jan. 5, 2017, no pet.) (mem. op.).
    We conclude that appellees’ direct claims against the QMP Appellants fall within the scope
    of the Distribution Agreement’s arbitration provision. We sustain appellants’ first issue.
    Conclusion
    We have decided both of appellants’ issues in their favor. Accordingly, we reverse the trial
    court’s order denying the motion to compel direct claims against the QMP Appellants to
    –14–
    arbitration. We render judgment ordering all disputes between these parties to proceed to
    arbitration, and we remand for further proceedings consistent with this opinion.
    /Bill Pedersen, III/
    BILL PEDERSEN, III
    JUSTICE
    180394F.P05
    –15–
    Court of Appeals
    Fifth District of Texas at Dallas
    JUDGMENT
    QUALITY METRICS PARTNERS, LLC,                       On Appeal from the 101st Judicial District
    CLEARVIEW DIAGNOSTICS, LLC,                          Court, Dallas County, Texas
    CGK CONSULTING, LLC, CGK                             Trial Court Cause No. DC-17-03702.
    MEDICAL MANAGEMENT, LLC, CGK                         Opinion delivered by Justice Pedersen, III.
    MEDICAL VENTURES, LLC, BRODIE                        Justices Brown and Schenck participating.
    FLANDERS, MICHAEL MORALES,
    MICHAEL KNALL, ANTHONY KIM,
    AND CHRISTOPHER R. PEYTON,
    Appellants
    No. 05-18-00394-CV          V.
    GREG BLASINGAME; CAPRICIA
    LARSON; GABBY CONSULTING, LLC;
    AND DX POWER MOVES
    CONSULTING, LLC, Appellees
    In accordance with this Court’s opinion of this date, the order of the trial court is
    REVERSED and judgment is RENDERED ordering all disputes between these parties to
    proceed to arbitration.
    The case is REMANDED for further proceedings consistent with this opinion.
    It is ORDERED that appellants Quality Metrics Partners, LLC, Clearview Diagnostics,
    LLL, CGK Consulting, LLC, CGK Medical Management, LLC, CGK Medical Ventures, LLC,
    Brodie Flanders, Michael Morales, Michael Knall, Anthony Kim, and Christopher R. Peyton
    recover their costs of this appeal from appellees Greg Blasingame; Capricia Larson; Gabby
    Consulting, LLC; and DX Power Moves Consulting, LLC.
    Judgment entered this 26th day of August, 2019.
    –16–